You just read:

Medison Issues Letter to Shareholders of Knight Therapeutics, Outlining Qualified, Independent Director Nominees and Common-Sense Plan to Build Value

News provided by

Medison Biotech Ltd.

Apr 16, 2019, 08:30 ET